1、Taylor PN, Zhang L, Lee RWJ, et al. New insights into the pathogenesis
and nonsurgical management of Graves orbitopathy[ J]. Nat Rev
Endocrinol, 2020, 16(2): 104-116.Taylor PN, Zhang L, Lee RWJ, et al. New insights into the pathogenesis
and nonsurgical management of Graves orbitopathy[ J]. Nat Rev
Endocrinol, 2020, 16(2): 104-116.
2、Gilhus NE, Tzartos S, Evoli A, et al. Myasthenia gravis[ J]. Nat Rev Dis
Primers, 2019, 5(1): 30.Gilhus NE, Tzartos S, Evoli A, et al. Myasthenia gravis[ J]. Nat Rev Dis
Primers, 2019, 5(1): 30.
3、Lanzolla G, Marcocci C, Marinò M. Oxidative stress in Graves disease
and Graves orbitopathy[ J]. Eur Thyroid J, 2020, 9(Suppl 1): 40-50.Lanzolla G, Marcocci C, Marinò M. Oxidative stress in Graves disease
and Graves orbitopathy[ J]. Eur Thyroid J, 2020, 9(Suppl 1): 40-50.
4、Davies TF, Andersen S, Latif R, et al. Graves' disease[ J]. Nat Rev Dis
Primers, 2020, 6(1): 52.Davies TF, Andersen S, Latif R, et al. Graves' disease[ J]. Nat Rev Dis
Primers, 2020, 6(1): 52.
5、Song RH, Yao QM, Wang B, et al. Thyroid disorders in patients
with myasthenia gravis: A systematic review and meta-analysis[ J].
Autoimmun Rev, 2019, 18(10): 102368.Song RH, Yao QM, Wang B, et al. Thyroid disorders in patients
with myasthenia gravis: A systematic review and meta-analysis[ J].
Autoimmun Rev, 2019, 18(10): 102368.
6、Yang HW, Wang YX, Bao J, et al. Correlation of HLA-DQ and TNF-α
gene polymorphisms with ocular myasthenia gravis combined with
thyroid-associated ophthalmopathy[ J]. Biosci Rep, 2017, 37(2):
BSR20160440.Yang HW, Wang YX, Bao J, et al. Correlation of HLA-DQ and TNF-α
gene polymorphisms with ocular myasthenia gravis combined with
thyroid-associated ophthalmopathy[ J]. Biosci Rep, 2017, 37(2):
BSR20160440.
7、Claytor B, Li Y. Challenges in diagnosing coexisting ocular myasthenia
gravis and thyroid eye disease[ J]. Muscle Nerve, 2021, 63(5): 631-639.Claytor B, Li Y. Challenges in diagnosing coexisting ocular myasthenia
gravis and thyroid eye disease[ J]. Muscle Nerve, 2021, 63(5): 631-639.
8、Smith TJ, Hegedüs L. Graves' disease[ J]. N Engl J Med, 2016, 375(16):
1552-1565.Smith TJ, Hegedüs L. Graves' disease[ J]. N Engl J Med, 2016, 375(16):
1552-1565.
9、Bojikian KD, Francis CE. Thyroid eye disease and Myasthenia
gravis[ J]. Int Ophthalmol Clin, 2019, 59(3): 113-124.Bojikian KD, Francis CE. Thyroid eye disease and Myasthenia
gravis[ J]. Int Ophthalmol Clin, 2019, 59(3): 113-124.
10、Vargas ME, Warren FA, Kupersmith MJ. Exotropia as a sign of
myasthenia gravis in dysthyroid ophthalmopathy[ J]. Br J Ophthalmol,
1993, 77(12): 822-823.Vargas ME, Warren FA, Kupersmith MJ. Exotropia as a sign of
myasthenia gravis in dysthyroid ophthalmopathy[ J]. Br J Ophthalmol,
1993, 77(12): 822-823.
11、Akan O, Baysal-Kirac L. Ophthalmologic manifestations in myasthenia
gravis: presentation and prognosis[ J]. Acta Neurol Belg, 2021, 121(5):
1131-1140.Akan O, Baysal-Kirac L. Ophthalmologic manifestations in myasthenia
gravis: presentation and prognosis[ J]. Acta Neurol Belg, 2021, 121(5):
1131-1140.
12、Almog Y, Ben-David M, Nemet AY. Inferior oblique muscle paresis as a
sign of myasthenia gravis[ J]. J Clin Neurosci, 2016, 25: 50-53.Almog Y, Ben-David M, Nemet AY. Inferior oblique muscle paresis as a
sign of myasthenia gravis[ J]. J Clin Neurosci, 2016, 25: 50-53.
13、Cleary M, Williams GJ, Metcalfe RA. The pattern of extra-ocular muscle
involvement in ocular myasthenia[ J]. Strabismus, 2008, 16(1): 11-18.Cleary M, Williams GJ, Metcalfe RA. The pattern of extra-ocular muscle
involvement in ocular myasthenia[ J]. Strabismus, 2008, 16(1): 11-18.
14、Weinberg DA, Lesser RL, Vollmer TL. Ocular myasthenia: a protean
disorder[ J]. Surv Ophthalmol, 1994, 39(3): 169-210.Weinberg DA, Lesser RL, Vollmer TL. Ocular myasthenia: a protean
disorder[ J]. Surv Ophthalmol, 1994, 39(3): 169-210.